On this page of StockholderLetter.com we present the 4/20/2023 shareholder letter from Aclaris Therapeutics, Inc. — ticker symbol ACRS. Reading current and past ACRS letters to shareholders can bring important insights into the investment thesis.
2022 ANNUAL REPORT
EMPOWERING PATIENTS THROUGH KINOME INNOVATION
Dear Fellow Shareholders, It is my sincere honor to share this correspondence with you, in my K d ^ , but in the years d areas: PEOPLE d d/-1777, ' D D K : > K W d d/- ' Z , which Z t promoted < & K D Z ' t ' , our head D , W K / the PROCESS ^ / K areas such as K - d
D< d/- d/- : < d/-1777, and /d< : < d/- d </E to PROGRAMS d/-450) / K D< / remained & studies: W Z ) W W^ W t ,^ e consistent d/-1777 / d ^ : < / & W d/- s, we entered into a W W d/-1777 can : < s d/-1777, d/- / K /d< : < / / Phase 1 /d< : < d/- ch demonstrated that dose- /d< : < t Phase 1 d/- We intend to pursue u d/- / K D< / > our second D< d/- academic third party t t t D D President and K d , Inc
 • shareholder letter icon 4/20/2023 Letter Continued (Full PDF)
 • stockholder letter icon 4/25/2024 ACRS Stockholder Letter
 • stockholder letter icon 4/24/2025 ACRS Stockholder Letter
 • stockholder letter icon More "Drugs & Pharmaceuticals" Category Stockholder Letters
 • Benford's Law Stocks icon ACRS Benford's Law Stock Score = 83


ACRS 4/20/2023 Shareholder/Stockholder Letter Transcript:

2022
ANNUAL
REPORT

EMPOWERING
PATIENTS
THROUGH
KINOME INNOVATION

Dear Fellow Shareholders,
It is my sincere honor to share this correspondence with you, in my
                                                                                        K                            
d                        ^                                                                                        
                                                                                        , but in the years
d                                                                                                                        
areas:                                                        
PEOPLE
d                                                                                                                                         d/-1777,                  

                                                            '                         D                                                        D             K                     

                                                :         >                                                                       K                                                     
                                                                                                                                                              W                
d                                                                                                         d/-                     '                       Z          , which
                                                                                                                                           Z                                         

t                                                                                                                                                                        promoted
<                                          &                 K                D           Z                  '                             t                             
'                           , our head       D ,                                                                                                                 
                                                                                            W                                                                                                  

K               /                              the                                                                                                                                    
PROCESS
^                                        /                                                                                                         K                                                
                     areas such as                                                                  
K                                                                                                                                           -                                   
                                        d                                                                                                                                               

                     D<                         d/-               d/-                                                 : <                              d/-1777, and
       /d<  : <                         d/-            d                                                                   our second D<                         d/-                                                                             
academic third party    t                                                                                                                                                   
                                                                                             t                                                                                    


t                             
        D             D     
President and                           K        
              d                    , Inc  



shareholder letter icon 4/20/2023 Letter Continued (Full PDF)
 

ACRS Stockholder/Shareholder Letter (Aclaris Therapeutics, Inc.) 4/20/2023 | www.StockholderLetter.com
Copyright © 2023 - 2026, All Rights Reserved

Nothing in StockholderLetter.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy.